Sema4D expression in PBMCs of ALL and AML patients and BMMCs of ALL patients was not correlated with risk classification, early remission status, extramedullary infiltration, chromosome translocation, and fusion genes (Tables S2-4). This evidence concerns the gene SEMA4D and acute lymphoblastic leukemia.